The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy

in Endocrine-Related Cancer
Authors:
Andrew M K Law Tumour Development Group, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
Cancer Biology Laboratory, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia

Search for other papers by Andrew M K Law in
Current site
Google Scholar
PubMed Close
,
Elgene Lim Connie Johnson Breast Cancer Research Laboratory, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales Australia, Sydney, New South Wales, Australia

Search for other papers by Elgene Lim in
Current site
Google Scholar
PubMed Close
,
Christopher J Ormandy Cancer Biology Laboratory, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales Australia, Sydney, New South Wales, Australia

Search for other papers by Christopher J Ormandy in
Current site
Google Scholar
PubMed Close
, and
David Gallego-Ortega Tumour Development Group, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales Australia, Sydney, New South Wales, Australia

Search for other papers by David Gallego-Ortega in
Current site
Google Scholar
PubMed Close

Correspondence should be addressed to D Gallego-Ortega; Email: d.gallego@garvan.org.au
DOI:
https://doi.org/10.1530/ERC-16-0404e
Volume/Issue:
Volume 24: Issue 7
Article Type:
Correction
Page Range:
X1
Online Publication Date:
Jul 2017
Copyright:
© 2017 Society for Endocrinology 2017
A RELATED ARTICLE IS AVAILABLE
Free access

Sign up for journal news

The authors and journal apologise for an error in the above paper, which appeared in volume 24 part 4, pages R123–R144. The error relates to the Funding section on page R135.

The original paper stated:

DGO is supported by a Garvan Foundation Fellowship generously sponsored by May Dariymple.’

This should have stated:

DGO is supported by the Garvan Research Foundation and generous donor, Mrs May Dalrymple.’

Endocrine-Related Cancer is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

More information is on the Reasons to publish page.

Sept 2018 onwards Past Year Past 30 Days
Full Text Views 321 169 29
PDF Downloads 112 53 7

 

  • Collapse
  • Expand
Print ISSN:
1351-0088
Online ISSN:
1479-6821
Copyright:
© 2017 Society for Endocrinology 2017
Print Publication Date:
01 Jul 2017
Online Publication Date:
Jul 2017